Cracking the Agg: How active fixed income can...

Biotech investing often hinges on understanding science, trials and patient outcomes. Dr. Judith Finegold is a physician turned equity analyst, and she explains how her clinical experience helps assess drug pipelines, clinical trials and long term risk in biotech investing — well ...  Show more

Capital Group equity portfolio manager Chris Buchbinder and economist Jared Franz stress test the bull and bear cases for AI. They cover whether we are in an AI boom or bubble and what productivity gains could mean for the U.S. economy and job markets. This podcast is from a rece ...  Show more

In the latest edition of Omni Talk’s Retail Fast Five, sponsored by the A&M Consumer and Retail Group, Mirakl, Simbe, Infios and Ocampo Capital Chris Walton and Anne Mezzenga discuss how Kroger is betting big on e-commerce—but is its strategy already flawed? In this segment, brou ...  Show more

Today’s show is the first in a mini-series on the changing landscape of retail. 

We’ve been hearing about the death of retail for more than five years now. There is no question that retail is changing. Perhaps the biggest effect is the blurry line between online and off ...

In the latest edition of Omni Talk’s Retail Fast Five sponsored by the A&M Consumer and Retail Group, Avalara, Mirakl, Ownit AI and Ocampo Capital Chris Walton, Anne Mezzenga, along with guest hosts from the Alvarez & Marsal Consumer and Retail Group David Ritter and Chad Lusk di ...  Show more

Stephanie’s cracked the hardest part – her Austin, TX, designer boutiques have seen record growth this past year despite the pandemic. She knows for a fact she’s taking sales away from the big hitters like Nordstroms, Revolve and Amazon - her customers just prefer the personal to ...  Show more